FN2 Earnings Intelligence

Eli Lilly and Company analyst ratings

Eli Lilly and Company (LLY) analyst consensus, price targets, and firm-level rating history from FN2 Research.

Analyst Consensus ?

ConsensusBuy46 ratings
Bullish3473.9%
Neutral919.6%
Bearish36.5%

Analyst 52W Price Targets

$1,417.99Current
$265Low
$1,057.18Average
$1,650High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 5, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Cantor Fitzgerald Overweight OverweightMaintainNov 2, 2026
Wells Fargo Overweight OverweightMaintainOct 30, 2026
UBS Buy BuyMaintainOct 30, 2026
Truist Securities Buy BuyMaintainOct 30, 2026
Scotiabank Sector Outperform Sector OutperformMaintainOct 30, 2026
Show 41 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $1,417.99. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Cantor FitzgeraldCarter Gould$1,600$1,409.22 +12.8%Nov 2, 2026
RBC CapitalAnalyst unavailable$1,600$1,425.34 +12.8%Oct 30, 2026
Argus ResearchJasper Hellweg$1,550$1,373 +9.3%Oct 30, 2026
UBSMichael Yee$1,625$1,373 +14.6%Oct 30, 2026
BMO CapitalEvan Seigerman$1,650$1,373 +16.4%Oct 30, 2026
See 139 more

Track every rating change on LLY the moment it posts. Free to start.

Start free

Get the LLY recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.